NCT05802758: CFT+VR

CFT-focused Mental Health Intervention With Exposure Training for Youngsters

Recruiting now NA Last updated 1 August 2023

What this trial tests

NA trial testing Psychopathy.comp and training in virtual reality (VR) in Conduct Disorder in 144 participants. Currently enrolling.

Timeline

1 January 2023

Primary endpoint
30 September 2028

31 December 2029

Quick facts

Lead sponsor	Helsinki University Central Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	144
Start date	1 January 2023
Primary completion	30 September 2028
Estimated completion	31 December 2029
Sites	2 locations across Finland

Drugs / interventions tested

• Psychopathy.comp and training in virtual reality (VR)

Conditions studied

• Conduct Disorder — all drugs for Conduct Disorder →
• Psychopathic Personality Trait — all drugs for Psychopathic Personality Trait →

Sponsor

Helsinki University Central Hospital

Who can join

Adults 15 to 20, male only, with Conduct Disorder or Psychopathic Personality Trait. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to explore if individual CFT-based intervention with exposure training in virtual reality decreases conduct disorder symptoms and callous-unemoitonal traits , as well as increases subjective emotional welbeing among 15-to-20 year-old male prisoners and boys placed to state's residential schools. We will also study factors that may predict adherence to the intervention. These factors include mental well-being, motivation, and working alliance. In addition, we will evaluate the costs of the program.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.